Pioglitazone Improved Insulin Sensitivity and First Phase Insulin Secretion Among Obese and Lean People with Diabetes: A Multicenter Clamp Study

INTRODUCTION: To investigate the effects of pioglitazone (PIO) on insulin resistance and first phase insulin secretion among obese and lean Chinese people with type 2 diabetes mellitus (T2DM). METHODS: Sixty-eight drug-naïve patients with T2DM were treated with PIO for 16 weeks. Before and after the...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Xin, Wang, Hui, Yang, Gangyi, Gao, Zhengnan, Luo, Yong, Dong, Aimei, Zhang, Fang, Xu, Mingtong, Liu, Shiping, Yang, Xin, Chen, Yanyan, Li, Guangwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104278/
https://www.ncbi.nlm.nih.gov/pubmed/29536426
http://dx.doi.org/10.1007/s13300-018-0401-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104278/
https://www.ncbi.nlm.nih.gov/pubmed/29536426
http://dx.doi.org/10.1007/s13300-018-0401-9

Ejemplares similares